Q2 2013

Filed Aug 7, 2013 · 10-Q · 38 days after period end · 0001193125-13-324514

Q2 2013 · 10-Q

Revenue—

Net Income

-$5.87M

N/M vs Q2 2012

EPS Diluted

-$0.15

N/M vs Q2 2012

Operating Cash Flowderived-$3,778,025N/M

Free Cash Flow

Same quarter

Metric	Q2 2013	Q2 2012	Q2 2011	Q2 2010
Revenue	—	$249.00K	$234.10K	$244.13K
Net Income	-$5.87M	$833.00K	-$4.04M	-$4.61M
EPS Diluted	-$0.15	$0.03	-$0.29	-$0.38

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Microbot Medical Inc. · CIK 883975 · Engraved from SEC EDGAR